Rheumatoid Arthritis Treatment Market: By Drugs Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease Modifying Anti-Rheumatic Drugs (DMARDs)), By Treatment (Synovectomy, Tendon Repair, Joint Fusion), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Rheumatoid Arthritis Treatment Market Size was valued at USD 53,876.2 million in 2022 and is poised to grow at a CAGR of 4.7% from 2023-29. Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. In RA, the body's immune system mistakenly attacks its own joint tissues, leading to inflammation, pain, stiffness, and potential joint damage over time. This condition can affect people of all ages but is more common in middle-aged and older adults, and it often affects multiple joints simultaneously. The goal of RA treatment is to manage symptoms, prevent joint damage, improve joint function, and enhance the patient's quality of life. Treatment approaches typically involve a combination of medications, lifestyle modifications, and in some cases, surgery. The increasing prevalence of rheumatoid arthritis (RA) plays a pivotal role in driving the revenues of the rheumatoid arthritis treatment market. As RA becomes more prevalent globally, with millions of people affected by this autoimmune disease, there is a growing demand for effective treatments to manage its debilitating symptoms. The aging population, coupled with lifestyle factors, contributes to the rise in RA cases. This surge in patient numbers creates a larger pool of individuals seeking medical care and therapies to alleviate pain, reduce inflammation, and prevent joint damage.

Advancements in treatment options are a significant driving force behind the growth of the rheumatoid arthritis treatment market. Continuous research and innovation have led to the development of newer and more effective medications and therapies for managing RA. Biologics, targeted therapies, and advanced disease-modifying antirheumatic drugs (DMARDs) offer superior symptom control, reduced side effects, and improved outcomes compared to traditional treatments. These innovative options not only enhance the quality of life for RA patients but also encourage more individuals to seek early diagnosis and treatment initiation, as they have greater confidence in the effectiveness of these therapies. However, high costs associated with biological DMARD therapies may hinder the growth of the market over future years. Meanwhile, increased healthcare spending and improved access to medical care in many regions create significant opportunities for the development of the market. Key market players are developing innovative treatment solutions to further contribute to the market growth. For example, in September 2021, Lupin launched the authorized generic version of duexise (ibuprofen and famotidine) tablets of Horizon Medicines LLC in the US market. 

Rheumatoid Arthritis Treatment Market Key Developments:       
  • In February 2021, Pfizer partnered with Imcyse for the potential treatment of rheumatoid arthritis (RA) via Imcyse’s RA program based on its Imotope technology
  • In June 2018, Eli Lilly and Company and Incyte Corporation announced the U.S. Food and Drug Administration (FDA) approval of 2-mg dose of OLUMIANT (baricitinib), for the treatment of active rheumatoid arthritis (RA).

Global Rheumatoid Arthritis Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Rheumatoid Arthritis Treatment Market Dynamics

owing introduction of newer therapies into the market and availability of FDA approved biologic drugs such as rituximab, abatacept, etanercept, etc. are expected to fuel consumption of rheumatoid arthritis treatment market. Moreover, emerging economies are highly adopting towards novel technologies and therapies and increase in disposable income and products that are ready to get approval from FDA for the treatment of rheumatoid arthritis expected to propel the growth of the market. However, high costs associated with biological DMARD therapies may hinder the growth of the market over future years.Conventional DMARDs is the most common therapy for Rheumatoid Arthritis. These drugs are available in different dosage forms including oral as well as parenteral, each dosage form having a different treatment regime. Biological DMARD includes biologic agents that are approved for the treatment of rheumatoid arthritis. Any biologic treatment that is not approved by the regulatory authorities or is under investigation is beyond the scope of this report.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Rheumatoid Arthritis Treatment Market Segmentation

By Drugs Type
  • Non-Steroidal anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Disease modifying anti-rheumatic drugs (DMARDs)
    • Conventional DMARD
    • Biologic DMARD
By Treatment Type
  • Synovectomy
  • Tendon Repair
  • Joint Fusion
By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and africa

Frequently Asked Questions

The Rheumatoid Arthritis Treatment Market Size was valued at USD 22.9 billion in 2022

The Rheumatoid Arthritis Treatment Market Key Players are AbbVie Inc. Johnson & Johnson Services Amgen Inc. Pfizer Cadila Healthcare Ltd. Novartis AG. AstraZeneca Hoffman-La Roche Ltd Bristol-Myers Squibb Company

Asia Pacific is the fastest growing region in Rheumatoid Arthritis Treatment Market

  1. Executive Summary
  2. Global Rheumatoid Arthritis Treatment Market Introduction
    • Global Rheumatoid Arthritis Treatment Market Taxonomy
    • Global Rheumatoid Arthritis Treatment Market Definitions
      • By Drugs Type
      • By Treatment Type
      • By End User
  3. Global Rheumatoid Arthritis Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Rheumatoid Arthritis Treatment Market Dynamics Factors Impact Analysis
  4. Global Rheumatoid Arthritis Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  5. Global Rheumatoid Arthritis Treatment Market Forecast, By Drugs Type, 2018 - 2022 and Forecast, 2023 - 2029
    • Non-Steroidal anti-inflammatory Drugs (NSAIDs)
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Corticosteroids
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Disease modifying anti-rheumatic drugs (DMARDs)
      • Conventional DMARD
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Biologic DMARD
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
  1. Global Rheumatoid Arthritis Treatment Market Forecast, By Treatment, 2018 - 2022 and Forecast, 2023 - 2029
    • Synovectomy
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Tendon Repair
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Joint Fusion
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Rheumatoid Arthritis Treatment Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
    • Hospitals
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Surgical Centers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Rheumatoid Arthritis Treatment Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Rheumatoid Arthritis Treatment Market - Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Region, 2023 - 2029
  2. North America Rheumatoid Arthritis Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Drugs Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Non-Steroidal anti-inflammatory Drugs (NSAIDs)
      • Corticosteroids
      • Disease modifying anti-rheumatic drugs (DMARDs)
        • Conventional DMARD
        • Biologic DMARD
      • Treatment Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Synovectomy
        • Tendon Repair
        • Joint Fusion
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Ambulatory Surgical Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • US
        • Canada
      • North America Rheumatoid Arthritis Treatment Market - Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2023 - 2029
      • North America Rheumatoid Arthritis Treatment Market Dynamics Trends
  1. Europe Rheumatoid Arthritis Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Drugs Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Non-Steroidal anti-inflammatory Drugs (NSAIDs)
      • Corticosteroids
      • Disease modifying anti-rheumatic drugs (DMARDs)
        • Conventional DMARD
        • Biologic DMARD
      • Treatment Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Synovectomy
        • Tendon Repair
        • Joint Fusion
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Ambulatory Surgical Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • UK
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
      • Europe Rheumatoid Arthritis Treatment Market - Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2023 - 2029
      • Europe Rheumatoid Arthritis Treatment Market Dynamics Trends
  1. Asia Pacific Rheumatoid Arthritis Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Drugs Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Non-Steroidal anti-inflammatory Drugs (NSAIDs)
      • Corticosteroids
      • Disease modifying anti-rheumatic drugs (DMARDs)
        • Conventional DMARD
        • Biologic DMARD
      • Treatment Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Synovectomy
        • Tendon Repair
        • Joint Fusion
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Ambulatory Surgical Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • China
        • Japan
        • India
        • ASEAN Counties
        • Philippines
        • Rest of Asia Pacific
      • Asia Pacific Rheumatoid Arthritis Treatment Market - Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2023 - 2029
      • Asia Pacific Rheumatoid Arthritis Treatment Market Dynamics Trends
  1. Latin America Rheumatoid Arthritis Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Drugs Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Non-Steroidal anti-inflammatory Drugs (NSAIDs)
      • Corticosteroids
      • Disease modifying anti-rheumatic drugs (DMARDs)
        • Conventional DMARD
        • Biologic DMARD
      • Treatment Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Synovectomy
        • Tendon Repair
        • Joint Fusion
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Ambulatory Surgical Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Mexico
        • Brazil
        • Argentina
        • Chile
        • Rest of Latin America
      • Latin America Rheumatoid Arthritis Treatment Market - Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2023 - 2029
      • Latin America Rheumatoid Arthritis Treatment Market Dynamics Trends
  1. Middle East and Africa Rheumatoid Arthritis Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Drugs Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Non-Steroidal anti-inflammatory Drugs (NSAIDs)
      • Corticosteroids
      • Disease modifying anti-rheumatic drugs (DMARDs)
        • Conventional DMARD
        • Biologic DMARD
      • Treatment Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Synovectomy
        • Tendon Repair
        • Joint Fusion
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals
        • Diagnostic Centers
        • Ambulatory Surgical Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • GCC Countries
        • South Africa
        • Saudi Arabia
        • Turkey
        • Rest of MEA
      • Middle East and Africa Rheumatoid Arthritis Treatment Market - Opportunity Analysis Index, By Drugs Type, By Treatment Type, By End User, and Country, 2023 - 2029
      • Middle East and Africa Rheumatoid Arthritis Treatment Market Dynamics Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • AbbVie Inc.
      • Johnson & Johnson Services
      • Amgen Inc.
      • Pfizer
      • Cadila Healthcare Ltd.
      • Novartis AG.
      • AstraZeneca
      • Hoffman-La Roche Ltd
      • Bristol-Myers Squibb Company
      • GlaxoSmithKline
  2. Research Methodology
  3. Key Assumptions and Acronyms
  • AbbVie Inc.
  • Johnson & Johnson Services
  • Amgen Inc.
  • Pfizer
  • Cadila Healthcare Ltd.
  • Novartis AG.
  • AstraZeneca
  • Hoffman-La Roche Ltd
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline

Adjacent Markets